You need to enroll in this course to view this chapter
Phase 1 Trial of MLN0128 (Sapanisertib) and CB-839 HCl (Telaglenastat) in Patients w/ Advanced NSCLC
0% Course Complete
Phase 1 Trial of MLN0128 (Sapanisertib) and CB-839 HCl (Telaglenastat) in Patients w/ Advanced NSCLC Attachments
100%
Page 1 of ?/?
Go to:
Loading PDF...